A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.

Udai Banerji; Natalie Cook; T.R. Jeffry Evans; Irene Moreno Candilejo; Patricia Roxburgh; Claire L. S. Kelly; Narmatha Sabaratnam; Rashmi Passi; Sawretse Leslie; Sidath Katugampola; Lisa Godfrey; Neil Tremayne; Gavin Bennett; Maria Koehler; Gillian Langford; Stefan N. Symeonides; Marc Pittman

doi:10.1200/jco.2018.36.15_suppl.tps2610

A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.

Udai Banerji, Natalie Cook, T.R. Jeffry Evans, Irene Moreno Candilejo, Patricia Roxburgh, Claire L. S. Kelly, Narmatha Sabaratnam, Rashmi Passi, Sawretse Leslie, Sidath Katugampola, Lisa Godfrey, Neil Tremayne, Gavin Bennett, Maria Koehler, Gillian Langford, Stefan N. Symeonides, Marc Pittman

Division of Cancer Sciences (L5)

Research output: Contribution to conference › Abstract › peer-review

Abstract

TPS2610Background: Membrane type I matrix metalloproteinase (MT1-MMP) is a member of the matrix metalloproteinase (MMP) family which are involved in tissue remodelling through proteolysis of extrac...

Original language	English
Pages	TPS2610-TPS2610
DOIs	https://doi.org/10.1200/jco.2018.36.15_suppl.tps2610
Publication status	Published - 20 May 2018

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2018.36.15_suppl.tps2610

Cite this

Banerji, U., Cook, N., Evans, T. R. J., Moreno Candilejo, I., Roxburgh, P., Kelly, C. L. S., Sabaratnam, N., Passi, R., Leslie, S., Katugampola, S., Godfrey, L., Tremayne, N., Bennett, G., Koehler, M., Langford, G., Symeonides, S. N., & Pittman, M. (2018). A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.. TPS2610-TPS2610. https://doi.org/10.1200/jco.2018.36.15_suppl.tps2610

@conference{71a8c7be1106408da0052b67c4e39776,

title = "A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.",

abstract = "TPS2610Background: Membrane type I matrix metalloproteinase (MT1-MMP) is a member of the matrix metalloproteinase (MMP) family which are involved in tissue remodelling through proteolysis of extrac...",

author = "Udai Banerji and Natalie Cook and Evans, {T.R. Jeffry} and {Moreno Candilejo}, Irene and Patricia Roxburgh and Kelly, {Claire L. S.} and Narmatha Sabaratnam and Rashmi Passi and Sawretse Leslie and Sidath Katugampola and Lisa Godfrey and Neil Tremayne and Gavin Bennett and Maria Koehler and Gillian Langford and Symeonides, {Stefan N.} and Marc Pittman",

year = "2018",

month = may,

day = "20",

doi = "10.1200/jco.2018.36.15_suppl.tps2610",

language = "English",

pages = "TPS2610--TPS2610",

}

Banerji, U, Cook, N, Evans, TRJ, Moreno Candilejo, I, Roxburgh, P, Kelly, CLS, Sabaratnam, N, Passi, R, Leslie, S, Katugampola, S, Godfrey, L, Tremayne, N, Bennett, G, Koehler, M, Langford, G, Symeonides, SN & Pittman, M 2018, 'A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.', pp. TPS2610-TPS2610. https://doi.org/10.1200/jco.2018.36.15_suppl.tps2610

TY - CONF

T1 - A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.

AU - Banerji, Udai

AU - Cook, Natalie

AU - Evans, T.R. Jeffry

AU - Moreno Candilejo, Irene

AU - Roxburgh, Patricia

AU - Kelly, Claire L. S.

AU - Sabaratnam, Narmatha

AU - Passi, Rashmi

AU - Leslie, Sawretse

AU - Katugampola, Sidath

AU - Godfrey, Lisa

AU - Tremayne, Neil

AU - Bennett, Gavin

AU - Koehler, Maria

AU - Langford, Gillian

AU - Symeonides, Stefan N.

AU - Pittman, Marc

PY - 2018/5/20

Y1 - 2018/5/20

N2 - TPS2610Background: Membrane type I matrix metalloproteinase (MT1-MMP) is a member of the matrix metalloproteinase (MMP) family which are involved in tissue remodelling through proteolysis of extrac...

AB - TPS2610Background: Membrane type I matrix metalloproteinase (MT1-MMP) is a member of the matrix metalloproteinase (MMP) family which are involved in tissue remodelling through proteolysis of extrac...

U2 - 10.1200/jco.2018.36.15_suppl.tps2610

DO - 10.1200/jco.2018.36.15_suppl.tps2610

M3 - Abstract

SP - TPS2610-TPS2610

ER -

A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.

Abstract

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Fingerprint

Cite this